Hear it from your peers

A device that can achieve sustained IOP reduction with few complications would empower surgeons to consider earlier surgical intervention, particularly for moderate to severe glaucoma.1,4

More Surgeon Perspectives

  • Video player still image of Dr I. Paul Singh

    Predictable Post-op

    “A device that enables IOP control even after a patient leaves our practice could help us better prevent progression.”

  • Video player still image of Dr Connie Okeke

    Sustainable Low IOP

    “It’s really important to have a surgical approach where we can get the pressure down and it’s sustained over a significant period of time.”

  • Video player still image of Dr Arsham Sheybani

    Device Innovation

  • Video still of Dr Paul Palmberg, Dr I. Paul Singh, Dr Leon Herndon, Dr Arsham Sheybani, Dr E. Randy Craven, and Dr Connie Okeke

    Video Library

    See glaucoma surgeons discuss ideas for how to improve patient outcomes

What is your experience?

Answer a question and see how your response compares with your peers’

What would best enable earlier surgical intervention in glaucoma patients with uncontrolled glaucoma despite maximally tolerated medical therapy?

With a growing prevalence of glaucoma, the need for earlier intervention is more acute5,6

*Based on the findings from the National Eye Institute and the Eye Diseases Prevalence Research Group.

Graphic depicting findings from the National Eye Institute and the Eye Diseases Prevalence Research Group

*Based on the findings from the National Eye Institute and the Eye Diseases Prevalence Research Group.

Data indicate that current glaucoma treatments are insufficient to arrest disease progression and preserve vision over a patient’s lifetime1,4

Graphic depicting findings from the Mayo Clinic

Based on findings from the Mayo Clinic.4

Earlier surgical intervention and aggressive disease management may result in better long-term outcomes1-3

Graphic depicting findings from the AGIS and TVT Study

Further device innovation is necessary to make earlier surgical intervention a credible option to halt disease progression and preserve vision.1-3

References: 1. Bloom P, Au L. “Minimally invasive glaucoma surgery (MIGS) is a poor substitute for trabeculectomy”—the great debate. Ophthalmol Ther. 2018;7(2):203-210. 2. Sihota R, Angmo D, Ramaswamy D, Dada T. Simplifying “target” intraocular pressure for different stages of primary open-angle glaucoma and primary angle-closure glaucoma. Indian J Ophthalmol. 2018;66(4):495-505. 3. Gedde SJ, Schiffman JC, Feuer WJ, et al; Tube Versus Trabeculectomy Study Group. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) Study after five years of follow-up. Am J Ophthalmol. 2012;153(5):789-803.e2. 4. Hattenhauer MG, Johnson DH, Ing HH, et al. The probability of blindness from open-angle glaucoma. Ophthalmology. 1998;105(11):2099-2104. 5. National Institutes of Health. National Eye Institute website. Glaucoma, open-angle tables. https://nei.nih.gov/eyedata/glaucoma/tables. Accessed July 21, 2019. 6. Friedman DS, Wolfs RC, O’Colmain BJ, et al; Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122(4):532-538. 7. Palmberg PF. The evolution of target pressure. Glaucoma Today. July/August 2014:33-35.

You are now leaving AdvancingGlaucomaSurgery.com

Click Continue to visit the external page you selected.